A systematic review has linked high-concentration THC cannabis products to negative mental health outcomes, particularly psychosis, schizophrenia, and cannabis use disorder. A new systematic review has examined how cannabis products with high levels of delta-9-tetrahydrocannabinol (THC) are linked to mental health outcomes. The analysis revealed that products with elevated THC concentrations are tied to negative […]



Summary

A systematic review confirms a strong association between high-THC cannabis products and adverse mental health effects. The research, analyzing cannabis products with elevated delta-9-tetrahydrocannabinol (THC) levels, found significant links to increased risks of psychosis, schizophrenia, and cannabis use disorder. This reinforces concerns about the potential harms of increasingly potent cannabis formulations on mental well-being. The review highlights the need for public health awareness and potentially stricter regulations concerning high-THC cannabis products.

Read more…

This post is part of “Science and Technology News”, Follow for more…!!!

Credits: Source

Disclaimer